Luxonus
Luxonus is a Japanese medical device company that develops photoacoustic 3D imaging systems using light and ultrasound to visualize blood and lymphatic vessels without radiation or contrast agents, serving hospitals and research institutions in Japan and Taiwan.
- Company typePrivate
- Founded2018
- HeadquartersSaiwai, Japan
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Luxonus firmographics
Firmographics- Name
- Luxonus
- Legal name
- 株式会社Luxonus
- Website
- https://luxonus.jp
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Luxonus is a Japanese medical device company that develops photoacoustic 3D imaging systems using light and ultrasound to visualize blood and lymphatic vessels without radiation or contrast agents, serving hospitals and research institutions in Japan and Taiwan.
- Ownership category
- akta.pro rank
Luxonus industry classification
Industry- Product category
- Medical Imaging Equipment
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Medical Equipment and Supplies Manufacturing (3391), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826), Optical Instruments & Lenses (3827)
- akta.pro primary industry
- Microscopy, Imaging & Flow Cytometry Instruments (HLAGAIAE)
- akta.pro secondary industry
- Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence) (HLAHADAH)
Keywords
Where Luxonus is headquartered
LocationHeadquarters
- HQ city
- Saiwai
- HQ country
- Japan
- HQ region
- Asia
Offices2 records
Markets served
Luxonus business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- Medical Device Sales (LME-01): Sales of the approved photoacoustic imaging medical device LME-01 to healthcare institutions for clinical diagnostic use.
- Research Instrument Sales (LRK-01): Sales of non-medical research-use photoacoustic 3D imaging systems for animal experiments, launched in October 2021.
- PAT Viewer Software: Freemium software model with basic free features and paid subscription for full functionality, or USB dongle purchase option. Subscription service launched in 2025.
- On-site Rental Services: Paid equipment usage services for non-clinical research and clinical research, including imaging support and image output assistance.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Others | PAT Viewer Free Tier |
| Subscription | Annual | PAT Viewer Full Features (Subscription) |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Luxonus product offering
Product offeringCore offering
Luxonus develops and manufactures photoacoustic 3D imaging (PAI) systems that combine pulsed laser light and ultrasound to capture radiation-free, high-resolution 3D images of blood vessels and lymphatic vessels. Its portfolio includes the clinically approved LME-01 medical imaging scanner, the LRK-01 animal-experiment research device, and the PAT Viewer 3D image analysis software. The company sells directly to hospitals and research institutions, primarily in Japan and Taiwan.
Product overview
Luxonus develops photoacoustic 3D imaging systems for medical and research applications. The product portfolio consists of the LME-01 (medical-grade photoacoustic imaging scanner for clinical use), the LRK-01 (research-use animal experiment imaging system), and PAT Viewer (proprietary 3D image visualization software). The LME-01 received regulatory approval in Japan as the first photoacoustic imaging device, while the LRK-01 serves preclinical research markets. PAT Viewer provides complementary image analysis capabilities for all imaging data. All products share the core photoacoustic technology platform using light and ultrasound hybrid imaging.
Differentiator
Problem solved
Functional benefit
Brands
- LME-01: Medical photoacoustic imaging device - Japan's first device based on photoacoustic principle, approved for clinical use
- LRK-01
- PAT Viewer
Products and services
- LME-01 Photoacoustic Imaging Scanner Regulatory-approved medical device for photoacoustic 3D imaging of blood vessels and lymphatic vessels, providing radiation-free, non-contrast imaging with ultra-high resolution for clinical diagnosis, surgical planning, and treatment monitoring in hospitals.
- LRK-01 Animal Experiment Photoacoustic Imaging Device Research-use, non-medical photoacoustic 3D imaging system for preclinical animal studies, enabling non-invasive, non-contrast vascular imaging with up to 0.1mm spatial resolution and a maximum imaging range of 180mm x 290mm.
- PAT Viewer 3D Image Viewer Software Proprietary GPU-accelerated 3D image viewer for Luxonus photoacoustic data, supporting image rotation, zooming, arbitrary shape trimming, Slab-MIP display, differential wavelength imaging, and vessel tracing analysis; offered as free basic version and paid subscription/USB dongle for full features.
- On-site Rental Imaging Service Paid equipment usage service allowing research and clinical institutions to use Luxonus photoacoustic imaging systems on-site at Luxonus facilities for non-clinical and clinical research, including imaging support and image output assistance.
Quantifiable outcome
- Maximum spatial resolution of 0.1mm for imaging microvessels
- +2 more outcomes
Companies that use Luxonus
Customer profileNamed customers2 records
Segments1 record
Ideal customer profiles2 records
Luxonus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature4 records
Luxonus partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, major and minor.
- 慶應義塾大学 (Keio University)coreCore research partner originating the photoacoustic imaging technology. Co-developed technology through ImPACT program. Ongoing clinical research collaboration including Keio University Hospital for medical device applications. Shared photoacoustic imaging project website.
- 京都大学 (Kyoto University)coreCore research partner for clinical applications including keloid research, flap surgery, and lymphatic imaging. Multiple joint publications and ongoing collaborative research programs.
- 国立研究開発法人日本医療研究開発機構 (AMED)majorSelected for AMED Advanced Medical Equipment Development Project (2019-2024). Government funding for clinical validation and regulatory approval process.
- 東京工業大学 (Tokyo Institute of Technology)minorAcademic research partner for photoacoustic imaging technology development. Joint presentation at SPIE BiOS 2023 on hemispherical detector array technology.
- 長瀬産業株式会社 (Nagase Sangyo)minorDistribution partner for ITEM2023 exhibition, hosting Luxonus technology display in their booth at international medical imaging exhibition.
Scale indicators7 records
Recent moves9 records
Expansion highlights6 records
Luxonus competitors and assessment
Company assessmentDirect peers
- iThera Medical: Germany-based developer of preclinical and clinical photoacoustic imaging systems. Competes with Luxonus in the same photoacoustic imaging modality, targeting vascular and molecular imaging applications across research and translational use.
- FUJIFILM VisualSonics: Subsidiary of FUJIFILM providing high-frequency ultrasound and photoacoustic imaging systems for preclinical research. Closely comparable to Luxonus's LRK-01 product line in animal and small-animal imaging markets.
- Endra Life Sciences: US-based developer of photoacoustic imaging technology (TAUS/Thermo-Acoustic Ultrasound) for fatty liver disease and other applications. Directly competes in commercializing photoacoustic imaging devices outside Japan.
- TomoWave: Developer of optoacoustic imaging systems for preclinical and clinical research, including the Nexus and Acuity systems. Directly comparable modality and customer segments to Luxonus's LRK-01.
- Seno Medical Instruments: Commercial-stage developer of optoacoustic/photoacoustic imaging for breast cancer diagnosis. Comparable in applying photoacoustic imaging to clinical vascular/tissue characterization indications.
Broad incumbents
- FUJIFILM Holdings: Global medical imaging incumbent that owns VisualSonics and offers a broad portfolio of imaging and healthcare IT products. Relevant as a parent of a direct peer and a potential strategic acquirer or competitive threat to Luxonus's technology.
- Canon Medical Systems: Japan-based global medical imaging incumbent offering CT, MRI, ultrasound, and diagnostic X-ray systems. Represents the established competitor whose installed base and reimbursement footprint Luxonus must disrupt in Japanese hospitals.
- GE HealthCare: Global medical imaging and diagnostics leader across MRI, CT, ultrasound, and PET. Defines the incumbent standard against which Luxonus's niche photoacoustic modality must differentiate on clinical and economic value.
- Siemens Healthineers: Global medical imaging and diagnostics major with deep hospital channel presence. Relevant incumbent for benchmarking Luxonus's enterprise sales motion and clinical adoption pathway.
Regional players
- Hitachi (Medical Systems): Japanese-headquartered provider of MRI, ultrasound, and diagnostic imaging systems. Comparable as a domestic Japan medical imaging competitor with established hospital relationships that Luxonus must navigate.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Luxonus social profiles
Digital presenceLuxonus compliance and trust
Trust signalCompliance2 records
Luxonus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Luxonus leadership team
Management profileNumber of profiles
Profiles7 records
Luxonus funding detail
Funding detailFunding overview
Funding rounds5 records
Investors12 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Luxonus M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Luxonus
What does Luxonus do?
Luxonus develops and manufactures photoacoustic 3D imaging (PAI) systems that combine pulsed laser light and ultrasound to capture radiation-free, high-resolution 3D images of blood vessels and lymphatic vessels. Its portfolio includes the clinically approved LME-01 medical imaging scanner, the LRK-01 animal-experiment research device, and the PAT Viewer 3D image analysis software. The company sells directly to hospitals and research institutions, primarily in Japan and Taiwan.
Is Luxonus a public or private company?
Luxonus is a private company. It is classified as venture growth investor backed and is currently operating.
When was Luxonus founded?
Luxonus was founded in 2018. It employs 11 to 50 people.
Where is Luxonus based?
Luxonus is headquartered in Saiwai, Japan, in the Asia region.
How does Luxonus make money?
Four revenue lines are on record. Medical Device Sales (LME-01) is the primary driver. The others are research Instrument Sales (LRK-01), PAT Viewer Software and on-site Rental Services.
Who are Luxonus's main competitors?
Direct peers on record are iThera Medical, FUJIFILM VisualSonics, Endra Life Sciences, TomoWave and Seno Medical Instruments. Broad incumbents are FUJIFILM Holdings, Canon Medical Systems, GE HealthCare and Siemens Healthineers. Hitachi (Medical Systems) is listed as a regional player.
Does Luxonus have an API?
No public API is recorded for Luxonus.
What industry is Luxonus in?
Luxonus's product category is Medical Imaging Equipment. Its primary akta.pro industry code is HLAGAIAE, Microscopy, Imaging & Flow Cytometry Instruments, with a secondary code of HLAHADAH, Intraoperative Imaging & Guidance (C-arms, O-arm, IOUS, fluorescence). Its NAICS code is 339112 and its SIC code is 3841.